Amgen price target raised to $329 from $310 at Piper Sandler
Piper Sandler raised the firm’s price target on Amgen (AMGN) to $329 from $310 and keeps an Overweight rating on the shares. The firm notes the ...
Reuters7d
Amgen profits rise, next MariTide studies start by mid-year
MariTide Phase 3 studies to begin in first half of year FDA places hold on AMG 513 obesity drug trial Amgen's Q4 earnings beat estimates, revenue up 11% Feb 4 (Reuters) - Amgen (AMGN.O), opens new ...
WRAL28d
Amgen’s $1 billion expansion in Holly Springs includes 12 apprentices from Wake Tech
Evans and Christian Stokes are among 12 apprentices who will be working for Amgen. “That's really amazing, especially for young people like in my generation that may not really have the ...
Yahoo4d
Amgen Stock Has Surged. Here’s Where It’s Headed Next.
Here’s Where It’s Headed Next. All of a sudden, Amgen stock is up 15% since late December to around $299. Its rise helped push up the healthcare sector up just over 7% since hitting a bottom ...
Yahoo Finance5d
Amgen profits rise, next MariTide studies start by mid-year
(Reuters) - Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug candidate MariTide will start before mid-year but regulators ...
Amgen Profits Rise, Next MariTide Studies Start by Mid-Year
(Reuters) - Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key ...